US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 2.500
  • -0.070-2.72%
Close Aug 16 16:00 ET
  • 2.500
  • 0.0000.00%
Post 20:02 ET
75.44MMarket Cap-871P/E (TTM)

Relmada Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-40.57%70.44M
-36.87%83.61M
-35.06%96.32M
-35.06%96.32M
-42.29%106.27M
-44.08%118.53M
-39.98%132.44M
-30.01%148.32M
-30.01%148.32M
109.06%184.15M
-Cash and cash equivalents
-85.58%2.09M
-95.38%1.34M
-24.17%4.09M
-24.17%4.09M
-84.25%6.7M
-61.17%14.47M
-35.70%28.89M
-87.86%5.4M
-87.86%5.4M
271.41%42.52M
-Short-term investments
-34.32%68.35M
-20.54%82.28M
-35.47%92.23M
-35.47%92.23M
-29.70%99.57M
-40.43%104.06M
-41.07%103.55M
-14.65%142.93M
-14.65%142.93M
84.80%141.63M
Receivables
----
----
--0
--0
--0
--0
--0
493.25%512.43K
493.25%512.43K
--0
-Other receivables
----
----
----
----
----
----
----
493.25%512.43K
493.25%512.43K
----
Prepaid assets
-84.53%537.52K
-75.65%752.33K
-70.63%1.19M
-70.63%1.19M
-4.05%2.83M
-0.26%3.47M
-69.05%3.09M
-64.30%4.04M
-64.30%4.04M
14.55%2.95M
Other current assets
----
----
----
----
-5.13%37
----
----
----
----
-99.97%39
Total current assets
-41.83%70.97M
-37.75%84.37M
-36.21%97.51M
-36.21%97.51M
-41.69%109.1M
-43.45%122M
-39.97%135.53M
-31.54%152.87M
-31.54%152.87M
105.87%187.11M
Non current assets
Other non current assets
55.03%53.63K
23.66%43.13K
23.66%43.13K
23.66%43.13K
196.46%47.72K
-1.84%34.59K
23.26%34.88K
23.26%34.88K
23.26%34.88K
-35.62%16.1K
Total non current assets
55.03%53.63K
23.66%43.13K
23.66%43.13K
23.66%43.13K
196.46%47.72K
-1.84%34.59K
23.26%34.88K
23.26%34.88K
23.26%34.88K
-65.95%16.1K
Total assets
-41.80%71.03M
-37.74%84.41M
-36.20%97.55M
-36.20%97.55M
-41.67%109.15M
-43.44%122.04M
-39.96%135.57M
-31.53%152.91M
-31.53%152.91M
105.78%187.12M
Liabilities
Current liabilities
Payables
-13.99%4.17M
17.35%5.19M
-33.37%3.51M
-33.37%3.51M
-72.60%2.86M
-35.63%4.85M
-58.56%4.42M
-52.99%5.26M
-52.99%5.26M
-17.96%10.43M
-accounts payable
-13.99%4.17M
17.35%5.19M
-33.37%3.51M
-33.37%3.51M
-72.60%2.86M
-35.63%4.85M
-58.56%4.42M
-52.99%5.26M
-52.99%5.26M
-17.96%10.43M
Current accrued expenses
-25.70%4.35M
14.45%6.5M
-8.10%5.68M
-8.10%5.68M
-51.85%4.1M
-41.68%5.85M
48.84%5.68M
177.73%6.19M
177.73%6.19M
100.08%8.52M
Other current liabilities
---20
----
-121.95%-9
-121.95%-9
-383.33%-34
----
----
78.26%41
78.26%41
200.00%12
Current liabilities
-10.89%9.54M
22.43%12.36M
-2.20%12.19M
-2.20%12.19M
-59.46%8.42M
-43.44%10.7M
-34.47%10.1M
-17.21%12.47M
-17.21%12.47M
13.86%20.78M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-10.89%9.54M
22.43%12.36M
-2.20%12.19M
-2.20%12.19M
-59.46%8.42M
-43.44%10.7M
-34.47%10.1M
-17.21%12.47M
-17.21%12.47M
13.86%20.78M
Shareholders'equity
Share capital
0.25%30.17K
0.25%30.17K
0.00%30.1K
0.00%30.1K
5.09%30.1K
0.25%30.1K
2.37%30.1K
8.50%30.1K
8.50%30.1K
63.65%28.64K
-common stock
0.25%30.17K
0.25%30.17K
0.00%30.1K
0.00%30.1K
5.09%30.1K
0.25%30.1K
2.37%30.1K
8.50%30.1K
8.50%30.1K
63.65%28.64K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-16.89%-600.5M
-19.31%-582.73M
-21.38%-560.9M
-21.38%-560.9M
-26.30%-535.74M
-33.53%-513.74M
-41.65%-488.43M
-51.48%-462.11M
-51.48%-462.11M
-56.70%-424.17M
Paid-in capital
5.91%661.96M
6.66%654.75M
7.26%646.23M
7.26%646.23M
7.78%636.43M
7.47%625.04M
10.57%613.87M
17.38%602.52M
17.38%602.52M
71.97%590.48M
Total stockholders'equity
-44.77%61.49M
-42.58%72.05M
-39.22%85.36M
-39.22%85.36M
-39.45%100.73M
-43.44%111.34M
-40.37%125.47M
-32.57%140.44M
-32.57%140.44M
128.85%166.34M
Total equity
-44.77%61.49M
-42.58%72.05M
-39.22%85.36M
-39.22%85.36M
-39.45%100.73M
-43.44%111.34M
-40.37%125.47M
-32.57%140.44M
-32.57%140.44M
128.85%166.34M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -40.57%70.44M-36.87%83.61M-35.06%96.32M-35.06%96.32M-42.29%106.27M-44.08%118.53M-39.98%132.44M-30.01%148.32M-30.01%148.32M109.06%184.15M
-Cash and cash equivalents -85.58%2.09M-95.38%1.34M-24.17%4.09M-24.17%4.09M-84.25%6.7M-61.17%14.47M-35.70%28.89M-87.86%5.4M-87.86%5.4M271.41%42.52M
-Short-term investments -34.32%68.35M-20.54%82.28M-35.47%92.23M-35.47%92.23M-29.70%99.57M-40.43%104.06M-41.07%103.55M-14.65%142.93M-14.65%142.93M84.80%141.63M
Receivables ----------0--0--0--0--0493.25%512.43K493.25%512.43K--0
-Other receivables ----------------------------493.25%512.43K493.25%512.43K----
Prepaid assets -84.53%537.52K-75.65%752.33K-70.63%1.19M-70.63%1.19M-4.05%2.83M-0.26%3.47M-69.05%3.09M-64.30%4.04M-64.30%4.04M14.55%2.95M
Other current assets -----------------5.13%37-----------------99.97%39
Total current assets -41.83%70.97M-37.75%84.37M-36.21%97.51M-36.21%97.51M-41.69%109.1M-43.45%122M-39.97%135.53M-31.54%152.87M-31.54%152.87M105.87%187.11M
Non current assets
Other non current assets 55.03%53.63K23.66%43.13K23.66%43.13K23.66%43.13K196.46%47.72K-1.84%34.59K23.26%34.88K23.26%34.88K23.26%34.88K-35.62%16.1K
Total non current assets 55.03%53.63K23.66%43.13K23.66%43.13K23.66%43.13K196.46%47.72K-1.84%34.59K23.26%34.88K23.26%34.88K23.26%34.88K-65.95%16.1K
Total assets -41.80%71.03M-37.74%84.41M-36.20%97.55M-36.20%97.55M-41.67%109.15M-43.44%122.04M-39.96%135.57M-31.53%152.91M-31.53%152.91M105.78%187.12M
Liabilities
Current liabilities
Payables -13.99%4.17M17.35%5.19M-33.37%3.51M-33.37%3.51M-72.60%2.86M-35.63%4.85M-58.56%4.42M-52.99%5.26M-52.99%5.26M-17.96%10.43M
-accounts payable -13.99%4.17M17.35%5.19M-33.37%3.51M-33.37%3.51M-72.60%2.86M-35.63%4.85M-58.56%4.42M-52.99%5.26M-52.99%5.26M-17.96%10.43M
Current accrued expenses -25.70%4.35M14.45%6.5M-8.10%5.68M-8.10%5.68M-51.85%4.1M-41.68%5.85M48.84%5.68M177.73%6.19M177.73%6.19M100.08%8.52M
Other current liabilities ---20-----121.95%-9-121.95%-9-383.33%-34--------78.26%4178.26%41200.00%12
Current liabilities -10.89%9.54M22.43%12.36M-2.20%12.19M-2.20%12.19M-59.46%8.42M-43.44%10.7M-34.47%10.1M-17.21%12.47M-17.21%12.47M13.86%20.78M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -10.89%9.54M22.43%12.36M-2.20%12.19M-2.20%12.19M-59.46%8.42M-43.44%10.7M-34.47%10.1M-17.21%12.47M-17.21%12.47M13.86%20.78M
Shareholders'equity
Share capital 0.25%30.17K0.25%30.17K0.00%30.1K0.00%30.1K5.09%30.1K0.25%30.1K2.37%30.1K8.50%30.1K8.50%30.1K63.65%28.64K
-common stock 0.25%30.17K0.25%30.17K0.00%30.1K0.00%30.1K5.09%30.1K0.25%30.1K2.37%30.1K8.50%30.1K8.50%30.1K63.65%28.64K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -16.89%-600.5M-19.31%-582.73M-21.38%-560.9M-21.38%-560.9M-26.30%-535.74M-33.53%-513.74M-41.65%-488.43M-51.48%-462.11M-51.48%-462.11M-56.70%-424.17M
Paid-in capital 5.91%661.96M6.66%654.75M7.26%646.23M7.26%646.23M7.78%636.43M7.47%625.04M10.57%613.87M17.38%602.52M17.38%602.52M71.97%590.48M
Total stockholders'equity -44.77%61.49M-42.58%72.05M-39.22%85.36M-39.22%85.36M-39.45%100.73M-43.44%111.34M-40.37%125.47M-32.57%140.44M-32.57%140.44M128.85%166.34M
Total equity -44.77%61.49M-42.58%72.05M-39.22%85.36M-39.22%85.36M-39.45%100.73M-43.44%111.34M-40.37%125.47M-32.57%140.44M-32.57%140.44M128.85%166.34M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg